s6y

3 Cidara Therapeutics, Inc.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0001209191-18-050649

Documents

  1. FORM 3 SUBMISSION 3
  2. POA DOCUMENT EX-24.3_809240

On sec.gov